PUNE, India, February 14, 2018 /PRNewswire/ --
According to a new market research "In Vivo Toxicology Market by Product (Instruments, Consumables (Animal models, Reagents & Kits)), Testing type (Chronic, Sub-chronic), Toxicity Endpoints (Immunotoxicity, Systemic, DART), Testing Facility (Outsourced, In-house) - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 6.14 Billion by 2022 from an estimated USD 4.40 Billion in 2017, at a CAGR of 6.9%. The key factors driving the growth of this market include increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests.
Browse 124 tables and 38 figures spread through 196 pages and in-depth TOC on "In Vivo Toxicology Market"
Early buyers will receive 10% customization on this report
The consumables segment is expected to hold the largest share of the market
Based on product, the In Vivo Toxicology Market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. In 2017, the consumables segment is expected to account for the largest share of the In Vivo Toxicology Market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.
By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period
Inquiry Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=105308811
The In Vivo Toxicology Market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.
The US is expected to dominate the In Vivo Toxicology Market in 2017
In 2017, the US is estimated to account for the largest share of the In Vivo Toxicology Market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period. Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the In Vivo Toxicology Market in China.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownload.asp?id=105308811
The major players in the global In Vivo Toxicology Market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).
Browse Related Reports
LIFE SCIENCE INSTRUMENTATION MARKET by Technology (Spectroscopy, Chromatography, Flow Cytometry, NGS, PCR, Microscopy), Application (Research, Clinical), End User (Pharma-Biotech Companies, Food & Beverage Industry, Hospitals) - Global Forecast to 2022
MICE MODEL MARKET by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
630 Dundee Road
Northbrook, IL 60062
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets